• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细菌脂多糖对肺表面活性剂的干扰及其被多黏菌素 B 的逆转:功能与结构。

The Perturbation of Pulmonary Surfactant by Bacterial Lipopolysaccharide and Its Reversal by Polymyxin B: Function and Structure.

机构信息

Martin Biomedical Center and Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia.

Department of Physical Chemistry of Drugs, Faculty of Pharmacy, Comenius University in Bratislava, 832 32 Bratislava, Slovakia.

出版信息

Int J Mol Sci. 2018 Jul 5;19(7):1964. doi: 10.3390/ijms19071964.

DOI:10.3390/ijms19071964
PMID:29976869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6073772/
Abstract

After inhalation, lipopolysaccharide (LPS) molecules interfere with a pulmonary surfactant, a unique mixture of phospholipids (PLs) and specific proteins that decreases surface tension at the air⁻liquid interphase. We evaluated the behaviour of a clinically used modified porcine pulmonary surfactant (PSUR) in the presence of LPS in a dynamic system mimicking the respiratory cycle. Polymyxin B (PxB), a cyclic amphipathic antibiotic, is able to bind to LPS and to PSUR membranes. We investigated the effect of PxB on the surface properties of the PSUR/LPS system. Particular attention was paid to mechanisms underlying the structural changes in surface-reducing features. The function and structure of the porcine surfactant mixed with LPS and PxB were tested with a pulsating bubble surfactometer, optical microscopy, and small- and wide-angle X-ray scattering (SAXS/WAXS). Only 1% LPS (/ to surfactant PLs) prevented the PSUR from reaching the necessary low surface tension during area compression. LPS bound to the lipid bilayer of PSUR and disturbed its lamellar structure by swelling. The structural changes were attributed to the surface charge unbalance of the lipid bilayers due to LPS insertion. PxB acts as an inhibitor of structural disarrangement induced by LPS and restores original lamellar packing, as detected by polarised light microscopy and SAXS.

摘要

吸入后,脂多糖(LPS)分子会干扰肺表面活性剂,这是一种独特的磷脂(PLs)和特定蛋白质的混合物,可降低气液界面的表面张力。我们在模拟呼吸循环的动态系统中评估了一种临床使用的改良猪肺表面活性剂(PSUR)在 LPS 存在下的行为。多粘菌素 B(PxB)是一种环状两亲性抗生素,能够与 LPS 和 PSUR 膜结合。我们研究了 PxB 对 PSUR/LPS 系统表面性质的影响。特别关注了导致表面减少特征结构变化的机制。用脉动气泡表面张力仪、光学显微镜和小角/广角 X 射线散射(SAXS/WAXS)测试了与 LPS 和 PxB 混合的猪用表面活性剂的功能和结构。仅 1%的 LPS(/到表面活性剂 PLs)就阻止了 PSUR 在面积压缩过程中达到必要的低表面张力。LPS 与 PSUR 的脂质双层结合,并通过肿胀扰乱其层状结构。结构变化归因于 LPS 插入导致的脂质双层表面电荷失衡。PxB 作为 LPS 诱导的结构紊乱的抑制剂,通过偏光显微镜和 SAXS 检测到其恢复了原始的层状堆积。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/112c/6073772/2c6147d1b3d1/ijms-19-01964-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/112c/6073772/9357f0b6a627/ijms-19-01964-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/112c/6073772/ba46d6a674c0/ijms-19-01964-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/112c/6073772/7085a5faa267/ijms-19-01964-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/112c/6073772/2c6147d1b3d1/ijms-19-01964-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/112c/6073772/9357f0b6a627/ijms-19-01964-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/112c/6073772/ba46d6a674c0/ijms-19-01964-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/112c/6073772/7085a5faa267/ijms-19-01964-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/112c/6073772/2c6147d1b3d1/ijms-19-01964-g004.jpg

相似文献

1
The Perturbation of Pulmonary Surfactant by Bacterial Lipopolysaccharide and Its Reversal by Polymyxin B: Function and Structure.细菌脂多糖对肺表面活性剂的干扰及其被多黏菌素 B 的逆转:功能与结构。
Int J Mol Sci. 2018 Jul 5;19(7):1964. doi: 10.3390/ijms19071964.
2
Polymyxin B-Enriched Exogenous Lung Surfactant: Thermodynamics and Structure.富含多粘菌素B的外源性肺表面活性剂:热力学与结构
Langmuir. 2024 Apr 2;40(13):6847-6861. doi: 10.1021/acs.langmuir.3c03746. Epub 2024 Mar 19.
3
Restoration of surfactant activity by polymyxin B in lipopolysaccharide-potentiated injury of immature rabbit lungs.多粘菌素 B 对脂多糖增强的未成熟兔肺损伤中表面活性剂活性的恢复作用。
Sci Rep. 2021 Jan 8;11(1):22. doi: 10.1038/s41598-020-79679-z.
4
The Effect of Modified Porcine Surfactant Alone or in Combination with Polymyxin B on Lung Homeostasis in LPS-Challenged and Mechanically Ventilated Adult Rats.改良猪肺表面活性物质单独或与多粘菌素B联合应用对脂多糖诱导及机械通气成年大鼠肺内环境稳定的影响
Molecules. 2020 Sep 23;25(19):4356. doi: 10.3390/molecules25194356.
5
Polymyxin B/pulmonary surfactant mixtures have increased resistance to inactivation by meconium and reduce growth of gram-negative bacteria in vitro.多粘菌素B/肺表面活性物质混合物增强了对胎粪灭活的抵抗力,并在体外减少革兰氏阴性菌的生长。
Pediatr Res. 2006 Mar;59(3):407-11. doi: 10.1203/01.pdr.0000200806.32822.e6.
6
Biophysical and physiological properties of porcine surfactant enriched with polymyxin B.富含多粘菌素B的猪表面活性剂的生物物理和生理特性。
Biol Neonate. 2005;88(2):101-8. doi: 10.1159/000085524. Epub 2005 Apr 27.
7
Protein-lipid interactions and surface activity in the pulmonary surfactant system.肺表面活性物质系统中的蛋白质-脂质相互作用及表面活性
Chem Phys Lipids. 2006 Jun;141(1-2):105-18. doi: 10.1016/j.chemphyslip.2006.02.017. Epub 2006 Mar 20.
8
Pulmonary surfactant preserves viability of alveolar type II cells exposed to polymyxin B in vitro.肺表面活性剂可维持体外暴露于多粘菌素 B 的肺泡 II 型细胞的活力。
PLoS One. 2013 Apr 19;8(4):e62105. doi: 10.1371/journal.pone.0062105. Print 2013.
9
Enterobacter agglomerans lipopolysaccharide-induced changes in pulmonary surfactant as a factor in the pathogenesis of byssinosis.聚团肠杆菌脂多糖诱导的肺表面活性物质变化作为棉尘病发病机制中的一个因素。
J Clin Microbiol. 1988 Apr;26(4):778-80. doi: 10.1128/jcm.26.4.778-780.1988.
10
Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro.
Biochemistry. 1990 Sep 11;29(36):8424-9. doi: 10.1021/bi00488a032.

引用本文的文献

1
Histamine as a mediator of cross-talk between human lung mast cells and macrophages.组胺作为人肺肥大细胞与巨噬细胞之间相互作用的介质。
Sci Rep. 2025 Aug 30;15(1):31969. doi: 10.1038/s41598-025-17262-0.
2
Thermodynamic and Structural Study of Budesonide-Exogenous Lung Surfactant System.布地奈德-外源性肺表面活性剂系统的热力学与结构研究
Int J Mol Sci. 2024 Mar 4;25(5):2990. doi: 10.3390/ijms25052990.
3
Novel opportunities from bioimaging to understand the trafficking and maturation of intracellular pulmonary surfactant and its role in lung diseases.

本文引用的文献

1
Comparison of Polymyxin E and Polymyxin B as an Additive to Pulmonary Surfactant in Escherichia coli Pneumonia of Ventilated Neonatal Rabbits.多粘菌素E与多粘菌素B作为肺表面活性物质添加剂在新生兔机械通气大肠杆菌肺炎模型中的比较
Biomed Hub. 2017 Jun 24;2(2):1-9. doi: 10.1159/000475877. eCollection 2017 May-Aug.
2
Unravelling a Mechanism of Action for a Cecropin A-Melittin Hybrid Antimicrobial Peptide: The Induced Formation of Multilamellar Lipid Stacks.揭开一种抗菌肽 Cecropin A-Melittin 杂合肽作用机制的神秘面纱:多层层状脂质堆积的诱导形成。
Langmuir. 2018 Feb 6;34(5):2158-2170. doi: 10.1021/acs.langmuir.7b03639. Epub 2018 Jan 22.
3
从生物成像中探索新机遇,以了解细胞内肺表面活性剂的运输和成熟过程及其在肺部疾病中的作用。
Front Immunol. 2023 Aug 10;14:1250350. doi: 10.3389/fimmu.2023.1250350. eCollection 2023.
4
SARS-CoV-2 Spike Protein Activates Human Lung Macrophages.SARS-CoV-2 刺突蛋白激活人肺巨噬细胞。
Int J Mol Sci. 2023 Feb 3;24(3):3036. doi: 10.3390/ijms24033036.
5
An adverse outcome pathway for lung surfactant function inhibition leading to decreased lung function.一条导致肺功能下降的肺表面活性物质功能抑制的不良结局途径。
Curr Res Toxicol. 2021 May 27;2:225-236. doi: 10.1016/j.crtox.2021.05.005. eCollection 2021.
6
[Significance of Lipopolysaccharide Lipid A Gene Mutation of Extensively Drug-resistant on Polymyxin Resistance and Its Influence on Treatment].[广泛耐药菌脂多糖脂质A基因突变对多黏菌素耐药性的意义及其对治疗的影响]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2021 Jan;52(1):124-128. doi: 10.12182/20210160208.
7
Restoration of surfactant activity by polymyxin B in lipopolysaccharide-potentiated injury of immature rabbit lungs.多粘菌素 B 对脂多糖增强的未成熟兔肺损伤中表面活性剂活性的恢复作用。
Sci Rep. 2021 Jan 8;11(1):22. doi: 10.1038/s41598-020-79679-z.
8
The Effect of Modified Porcine Surfactant Alone or in Combination with Polymyxin B on Lung Homeostasis in LPS-Challenged and Mechanically Ventilated Adult Rats.改良猪肺表面活性物质单独或与多粘菌素B联合应用对脂多糖诱导及机械通气成年大鼠肺内环境稳定的影响
Molecules. 2020 Sep 23;25(19):4356. doi: 10.3390/molecules25194356.
9
Lipid-Protein and Protein-Protein Interactions in the Pulmonary Surfactant System and Their Role in Lung Homeostasis.肺表面活性剂系统中的脂质-蛋白和蛋白-蛋白相互作用及其在肺稳态中的作用。
Int J Mol Sci. 2020 May 25;21(10):3708. doi: 10.3390/ijms21103708.
Lipopolysaccharide Neutralization by Cationic-Amphiphilic Polymers through Pseudoaggregate Formation.
阳离子两亲性聚合物通过形成假聚集体实现脂多糖中和作用
Biomacromolecules. 2016 Mar 14;17(3):862-73. doi: 10.1021/acs.biomac.5b01567. Epub 2016 Feb 22.
4
Biophysicochemical Interaction of a Clinical Pulmonary Surfactant with Nanoalumina.一种临床肺表面活性剂与纳米氧化铝的生物物理化学相互作用
Langmuir. 2015 Jul 7;31(26):7346-54. doi: 10.1021/acs.langmuir.5b01639. Epub 2015 Jun 25.
5
Composition, structure and mechanical properties define performance of pulmonary surfactant membranes and films.组成、结构和机械性能决定了肺表面活性物质膜和片的性能。
Chem Phys Lipids. 2015 Jan;185:153-75. doi: 10.1016/j.chemphyslip.2014.09.002. Epub 2014 Sep 28.
6
Biophysical activity of animal-derived exogenous surfactants mixed with rifampicin.动物来源的外源性表面活性剂与利福平混合的生物物理活性。
Adv Exp Med Biol. 2015;839:31-9. doi: 10.1007/5584_2014_64.
7
Binding interactions of bacterial lipopolysaccharide and the cationic amphiphilic peptides polymyxin B and WLBU2.细菌脂多糖与阳离子两亲性肽多粘菌素B和WLBU2的结合相互作用。
Colloids Surf B Biointerfaces. 2014 Aug 1;120:81-7. doi: 10.1016/j.colsurfb.2014.05.004. Epub 2014 May 14.
8
Effectiveness of treatment with surfactant in premature infants with respiratory failure and pulmonary infection.表面活性剂治疗呼吸衰竭和肺部感染早产儿的疗效
Acta Biomed. 2012;83 Suppl 1:33-6.
9
Biophysical mechanisms of endotoxin neutralization by cationic amphiphilic peptides.阳离子两亲肽中和内毒素的生物物理机制。
Biophys J. 2011 Jun 8;100(11):2652-61. doi: 10.1016/j.bpj.2011.04.041.
10
Bacterial lipopolysaccharide promotes destabilization of lung surfactant-like films.细菌脂多糖促进肺表面活性剂样膜的不稳定性。
Biophys J. 2011 Jan 5;100(1):108-16. doi: 10.1016/j.bpj.2010.11.028.